宣传图

rsz_dsc07132_拷贝
DJI_0293 1
DJI_0297
DJI_0277

Product Category

APIs, Finished Preparation, Intermediate

About Us

Promote Human Health
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan. Loncom Pharma adheres to the R&D spirit of "Being rigorous, serious, focused and realistic", and takes ICH international guidelines as the standard to produce formulations and APIs continuously. At present, the company's products have covered cardiovascular and cerebrovascular system, digestive system, anti-tumor, nervous system, geriatric medicine, andrology medicine, pediatric medicine and other fields.

Core Product

Loncom Pharma has three API production workshops GMP certified by the state, as well as three production lines for tablets, hard capsules, dry suspensions and oral liquid preparations.
Abemaciclib 
CAS No.:1231929-97-7
Formula:C27H32F2N8
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine
View More
Darolutamide
CAS No.:1297538-32-9
Formula:C19H19ClN6O2
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide
View More
Upadacitinib
CAS No.:1310726-60-3
Formula:C17H19F3N6O
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo [7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
View More
Pharmaceutical Grade API Sorafenib Tosylate
CAS No.:475207-59-1
Formula:C28H24ClF3N4O6S
Type:Pharmaceutical API
Appearance:White or slightly yellowish or brownish powder
Certificate:GMP, COPP, WC, DMF, CEP
Shelf Life:2 years
Quality Standard:CP, EP, USP
Assay:97.5%-102.0%
Chemical Name:4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino] phenoxy]-N-methylpyridine-2-carboxamide;4- methylbenzenesulfonic acid
View More
 Osimertinib Mesylate
CAS No.:1421373-66-1
Formula:C29H37N7O5S
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide;methanesulfonic acid
View More
Sunitinib Malate
CAS No.:341031-54-7
Formula:C26H33FN4O7
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid
 
View More
Erlotinib Hydrochloride
CAS No.:183319-69-9
Formula:C22H24ClN3O4
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride
View More
Levosimendan
CAS No.:141505-33-1
Formula:C14H12N6O
Type:Pharmaceutical API
Appearance:Powder
Certificate:GMP, COPP, WC, DMF
Shelf Life:2 years
Quality Standard:CP, EP, JP, USP
Assay:98.0%-102.0%
Chemical Name:2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl] phenyl] hydrazinylidene]propanedinitrile
View More

Our Service

Stable, Professional, And Efficient Service

News of LONCOM - High-tech Pharmaceutical Company

12/ 10/ 2025
Biocom's Presence at Pharma Asia Expo: Exploring New Cooperation Opportunities

Recently, the highly influential pharmaceutical industry event in South Asia—the Pakistan Pharma Asia Expo—was grandly held in Karachi. Biocom conducted in-depth research into the South Asian market and actively engaged with industry partners.

no photo
11/ 28/ 2025
Making a Debut at Russia's Pharmtech Expo, Tapping into New Opportunities in the Eurasian Pharmaceutical Market

Biocom made a prominent appearance at the Russia Pharmtech Expo, showcasing its full-industry-chain capabilities and high-end API products, and reached preliminary cooperation intentions with clients across Eurasia. The team conducted in-depth research on the local industry ecosystem and assessed potential production bases, laying the groundwork for deeper regional collaboration and expansion into the Eurasian market. The company remains committed to driving high-quality development in the global pharmaceutical industry through innovation and quality excellence.

no photo
12/ 13/ 2023
Breaking Medical News: Sorafenib Tosylate Shows Promise in Advancing Cancer Treatment In a significant development in the field of oncology, a recent study has unveiled promising results for Sorafeni

Breaking Medical News: Sorafenib Tosylate Shows Promise in Advancing Cancer TreatmentIn a significant development in the field of oncology, a recent study has unveiled promising results for Sorafenib Tosylate, a tyrosine kinase inhibitor commonly used in the treatment of advanced liver and kidney ca

企业微信截图_17024591793720.png
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province.

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us